Related Experiment Video
Updated: Aug 12, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250
1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Abstract:
The retinoblastoma tumor suppressor protein, Rb, interacts directly with the largest TATA-binding protein-associated factor, TAFII250, through multiple regions in each protein. To define the potential role(s) of this interaction, we examined whether Rb could regulate the intrinsic, bipartite kinase activity of TAFII250. Here, we report that Rb is able to inhibit the kinase activity of immunopurified and gel-purified recombinant TAFII250. Rb inhibits the autophosphorylation of TAFII250 as well as its phosphorylation of the RAP74 subunit of TFIIF in a dose-responsive manner. Inhibition of TAFII250 kinase activity involves the Rb pocket (amino acids 379 to 928) but not its amino terminus. In addition, Rb appears to specifically inhibit the amino-terminal kinase domain of TAFII250 through a direct protein-protein interaction. We further demonstrate that two different tumor-derived Rb pocket mutants, C706F and Deltaex22, are functionally defective for kinase inhibition, even though they are able to bind the amino terminus of TAFII250. Our results suggest a novel mechanism of transcriptional regulation by Rb, involving direct interaction with TAFII250 and inhibition of its ability to phosphorylate itself, RAP74, and possibly other targets.
Insights
The retinoblastoma tumor suppressor protein (Rb) inhibits the kinase activity of TAFII250, a key transcription factor. This interaction, mediated by the Rb pocket, suggests a new way Rb regulates gene transcription.
Area of Science:
- Molecular Biology
- Cancer Research
- Transcriptional Regulation
Background:
- The retinoblastoma tumor suppressor protein (Rb) is crucial for cell cycle control.
- TAFII250 is a large subunit of the TFIID complex, involved in transcription initiation.
- Rb and TAFII250 interact, but the functional significance is unclear.
Purpose of the Study:
- To investigate whether Rb regulates the kinase activity of TAFII250.
- To elucidate the mechanism and functional domains involved in Rb-TAFII250 interaction.
Main Methods:
- Immunopurification and gel purification of recombinant TAFII250.
- In vitro kinase assays to measure TAFII250 autophosphorylation and RAP74 phosphorylation.
- Site-directed mutagenesis of Rb to identify functional domains.
Main Results:
- Rb inhibits the kinase activity of TAFII250 in a dose-dependent manner.
- Rb's inhibitory function resides in its pocket domain (aa 379-928), not the N-terminus.
- Rb specifically inhibits TAFII250's N-terminal kinase domain via direct interaction.
- Rb pocket mutants (C706F, Deltaex22) are defective in kinase inhibition despite binding TAFII250.
Conclusions:
- Rb directly inhibits TAFII250 kinase activity, suggesting a novel regulatory mechanism.
- This inhibition involves specific interaction with TAFII250's kinase domain.
- Rb's tumor suppressor function may involve modulating TAFII250's phosphorylation of itself and other targets like RAP74.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Receptor Tyrosine Kinases
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway

